pSivida Corp. (PSDV) - Product Pipeline Analysis

Document Sample
pSivida Corp. (PSDV)  - Product Pipeline Analysis Powered By Docstoc
					                                            pSivida Corp. (PSDV) - Product Pipeline Analysis

     Reference Code: GDME3119PD                                                                                               Publication Date: NOV 2010



     Company Snapshot                                                         Company Overview
     Key Information
                                                                              pSivida Limited (pSivida) is engaged in the manufacture and development
     pSivida Corp., Key Facts                                                 of drug delivery products for the healthcare markets. It develops drug
                                                                              delivery technologies that are used for the treatment of diseases such as
     Web Address                             www.psivida.com
                                                                              chronic eye disease, diabetic macular edema, inoperable pancreatic
     Turnover (in USD Million)               12.20                            cancer and numerous other applications. It has entered into various
                                                                              collaborations towards its drug development. The partners of the company
     Number of Employees                     22                               include Pfizer, Alimera Sciences, Intrinsiq Materials Cayman Limited
     Industry                                Pharmaceuticals and Healthcare   (Intrinsiq) and Bausch & Lomb. The company principally operates in the
     Source:Primary / Secondary Research                                      UK, and the US. It is headquartered in Maryland, the US
     GlobalData




     pSivida Corp. Pipeline Products

     pSivida Corp. Key Pipeline Products by Equipment Type                    pSivida Corp. Key Pipeline Products by Therapy Area

     Equipment Type                                         No of Products    Therapy Area                                             No of Products
     Injectable Drug Delivery                                    2            Diabetic macular edema                                       2
                                                                              Pancreatic cancer                                            1
     Source: Primary / Secondary Research                                     Source: Primary / Secondary Research
     GlobalData                                                               GlobalData




     pSivida Corp. Key Pipeline Products by Development Stage

     Developmental Stage                                                                                                               No of Products
     Clinicals                                                                                                       2
     Pre-Clinicals                                                                                                   2
     Early development                                                                                               -
     Source: Primary / Secondary Research
     GlobalData
     Note : (-) indicates 'Not Available'



     pSivida Corp. Key Pipeline Products by Trial Phase

     Trial Phase                                                                                                                       No of Products
     Phase IV                                                                                                        -
     Phase III                                                                                                       1
     Phase II                                                                                                        2
     Phase I                                                                                                         -
     Source: Primary / Secondary Research
     GlobalData
     Note : (-) indicates 'Not Available'




pSivida Corp. (PSDV) - Product Pipeline Analysis                                                                                  Reference Code: GDME3119PD

Source : www.globalcompanyintelligence.com                                                                                                                 Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 3
     List of Figures......................................................................................................................................................................................................................................................................... 4
     pSivida Corp. - Business Description..................................................................................................................................................................................................................................... 5
     Key Facts ............................................................................................................................................................................................................................................................................... 5
     pSivida Corp. - Major Products and Services ........................................................................................................................................................................................................................ 6
           pSivida Corp. Pipeline Products by Equipment Type ...................................................................................................................................................................................................... 7
           pSivida Corp. Pipeline Products by Development Stage................................................................................................................................................................................................. 9
           pSivida Corp. Pipeline Products by Therapy Area ........................................................................................................................................................................................................ 11
           pSivida Corp. Pipeline Products by Trial Phase ............................................................................................................................................................................................................ 13
           pSivida Corp. Pipeline Products by Milestone Summary .............................................................................................................................................................................................. 15
           AEON MEDIDUR........................................................................................................................................................................................................................................................... 17
                 Product Status......................................................................................................................................................................................................................................................... 17
                 Product Description ................................................................................................................................................................................................................................................. 17
                 Product Patent Details ............................................................................................................................................................................................................................................ 17
           Biosilicon........................................................................................................................................................................................................................................................................ 26
                 Product Status......................................................................................................................................................................................................................................................... 26
                 Product Description ................................................................................................................................................................................................................................................. 26
                 Product Patent Details ............................................................................................................................................................................................................................................ 26
           Biosilicon - BrachySil ..................................................................................................................................................................................................................................................... 28
                 Product Status......................................................................................................................................................................................................................................................... 28
                 Product Description ................................................................................................................................................................................................................................................. 29
                 Product Milestone ................................................................................................................................................................................................................................................... 29
                 Biosilicon - BrachySil Clinical Trial .......................................................................................................................................................................................................................... 29
                 Product Patent Details ............................................................................................................................................................................................................................................ 32
           Durasert ......................................................................................................................................................................................................................................................................... 34
                 Product Status......................................................................................................................................................................................................................................................... 34
                 Product Description ................................................................................................................................................................................................................................................. 34
                 Product Milestone ................................................................................................................................................................................................................................................... 34
           Iluvien Injection System ................................................................................................................................................................................................................................................. 35
                 Product Status......................................................................................................................................................................................................................................................... 35
                 Product Description ................................................................................................................................................................................................................................................. 35
                 Product Milestone ................................................................................................................................................................................................................................................... 35
                 Iluvien Injection System Clinical Trial ...................................................................................................................................................................................................................... 36
                 Product Patent Details ............................................................................................................................................................................................................................................ 38
     pSivida Corp. - Key Competitors.......................................................................................................................................................................................................................................... 39
     pSivida Corp. - Key Employees ........................................................................................................................................................................................................................................... 40
     pSivida Corp. - Key Employee Biographies ......................................................................................................................................................................................................................... 41
     pSivida Corp. - Locations And Subsidiaries ......................................................................................................................................................................................................................... 42
           Head Office.................................................................................................................................................................................................................................................................... 42
           Other Locations & Subsidiaries ..................................................................................................................................................................................................................................... 42
     Recent Developments.......................................................................................................................................................................................................................................................... 43
                 Sep 23, 2010: pSivida Reports Net Income Of $8.75 Million In Fiscal 2010........................................................................................................................................................... 43
                 May 12, 2010: pSivida Reports Q3 Fiscal 2010 Results......................................................................................................................................................................................... 43
                 Feb 11, 2010: pSivida Reports Total Revenues Of $3.4 Million In Q2 Fiscal 2010 ................................................................................................................................................ 43
                 Nov 12, 2009: pSivida Reports Total Revenues Of AUD3.4 Million In Q1 Fiscal 2010 .......................................................................................................................................... 44
                 Oct 14, 2009: pSivida's Phase III Iluvien Trial's Last Patient Completes Two-year Follow-up Visit........................................................................................................................ 44
                 Sep 24, 2009: pSivida Reports Revenue Of $12.2 Million For Fiscal 2009 ............................................................................................................................................................ 45
                 May 14, 2009: pSivida Reports Revenues Of $3.2 Million In Q3 Fiscal 2009......................................................................................................................................................... 45
                 Mar 12, 2009: psivida CFO Resigns ....................................................................................................................................................................................................................... 45
                 Feb 12, 2009: pSivida Reports Q2 Fiscal 2009 Results ......................................................................................................................................................................................... 46
                 Feb 03, 2009: pSivida Appoints President And CEO.............................................................................................................................................................................................. 46
     Appendix .............................................................................................................................................................................................................................................................................. 47
           Methodology .................................................................................................................................................................................................................................................................. 47
           About GlobalData .......................................................................................................................................................................................................................................................... 47
           Contact Us .....................................................
				
DOCUMENT INFO
Description: pSivida Corp. (PSDV) - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the pSivida Corp. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. Reasons to Buy
BUY THIS DOCUMENT NOW PRICE: $750 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.